| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2839643 | Clínica e Investigación en Arteriosclerosis | 2012 | 9 Pages |
Abstract
The coadministration of simvastatin and ezetimibe has an additive cholesterol-lowering effect. Furthermore, only simvastatin reduces atherogenic lipoprotein subfractions and exerts anti-inflammatory effects over longer periods of time.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
Antonio Hernández-Mijares, Celia Bañuls, Lorena Bellod, Ana Jover, Eva Solá, VÃctor M. VÃctor, Milagros Rocha,